Literature DB >> 31749082

Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.

J-W Feng1, H Pan1, L Wang1, J Ye1, Y Jiang2, Z Qu3.   

Abstract

BACKGROUND: Tumor multifocality is not uncommon in papillary thyroid carcinoma (PTC), especially in micro-PTC. However, assessing the size of the largest tumor may underestimate effect of additional foci. We aimed to investigate the effect of total tumor diameter (TTD) on clinicopathological features of micro-PTC.
METHODS: Data from 442 patients who underwent thyroidectomy with cervical lymph node dissection for PTC were retrospectively analyzed. Patients were classified into subgroups according to multifocality and TTD. The relationships of clinicopathological features among these groups were analyzed.
RESULTS: Multifocality was observed in 119 patients (26.9%). TTD > 1 cm and presence of extrathyroidal extension (ETE) were significantly higher in multifocal tumors compared to unifocal tumor (P < 0.001, P = 0.016, respectively). When comparing multifocal micro-PTC with TTD > 1 cm to those with unifocal micro-PTC or multifocal micro-PTC with TTD ≤ 1 cm, the proportions of cases with ETE, central lymph node metastasis (CLNM), and lateral lymph node metastasis (LLNM) were significantly higher (all P < 0.05). There was no significant difference in terms of these parameters between multifocal micro-PTC with TTD > 1 cm and macro-PTC or multifocal macro-PTC. The risk of CLNM was 2.056 (P = 0.044) times higher in multifocal micro-PTC with TTD > 1 cm than in unifocal micro-PTC.
CONCLUSION: For multifocal micro-PTC, TTD can better assess the aggressiveness of the tumor. Multifocal micro-PTC with TTD > 1 cm was more aggressive than unifocal micro-PTC or multifocal micro-PTC with TTD ≤ 1 cm.

Entities:  

Keywords:  Lymph node metastases; Multifocality; Papillary thyroid carcinoma; Recurrence-free survival; Total tumor diameter

Mesh:

Year:  2019        PMID: 31749082     DOI: 10.1007/s40618-019-01147-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.

Authors:  Samer R Rajjoub; Huan Yan; Natalie A Calcatera; Kristine Kuchta; Chi-Hsiung E Wang; Waseem Lutfi; Tricia A Moo-Young; David J Winchester; Richard A Prinz
Journal:  Surgery       Date:  2018-02-13       Impact factor: 3.982

3.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.

Authors:  Hyeyeun Lim; Susan S Devesa; Julie A Sosa; David Check; Cari M Kitahara
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

4.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

5.  Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma.

Authors:  Brian R Untch; Frank L Palmer; Ian Ganly; Snehal G Patel; R Michael Tuttle; Jatin P Shah; Ashok A Shaha
Journal:  Ann Surg Oncol       Date:  2013-12-24       Impact factor: 5.344

Review 6.  Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Svante Jansson; Marcin Barczyński; Peter Goretzki
Journal:  Langenbecks Arch Surg       Date:  2013-11-22       Impact factor: 3.445

7.  The increasing incidence of thyroid cancer: the influence of access to care.

Authors:  Luc G T Morris; Andrew G Sikora; Tor D Tosteson; Louise Davies
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

8.  Multifocality and bilaterality of papillary thyroid microcarcinoma.

Authors:  Yoon Kyoung So; Myung Woo Kim; Young-Ik Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

9.  Number of tumor foci predicts prognosis in papillary thyroid cancer.

Authors:  Ning Qu; Ling Zhang; Qing-hai Ji; Yong-xue Zhu; Zhuo-ying Wang; Qiang Shen; Yu Wang; Duan-shu Li
Journal:  BMC Cancer       Date:  2014-12-04       Impact factor: 4.430

10.  Insights into the Management of Papillary Microcarcinoma of the Thyroid.

Authors:  Akira Miyauchi; Yasuhiro Ito; Hitomi Oda
Journal:  Thyroid       Date:  2017-09-22       Impact factor: 6.568

View more
  8 in total

1.  Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaodong He
Journal:  Gland Surg       Date:  2020-06

2.  A Proposed Heterogeneous Ensemble Algorithm Model for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer.

Authors:  Wenfei Liu; Shoufei Wang; Xiaotian Xia; Minggao Guo
Journal:  Int J Gen Med       Date:  2022-05-06

3.  Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden.

Authors:  Jacopo Manso; Simona Censi; Amir Roberti; Maurizio Iacobone; Susi Barollo; Loris Bertazza; Francesca Galuppini; Federica Vianello; Nora Albinger; Carla Scaroni; Gianmaria Pennelli; Caterina Mian
Journal:  Ther Adv Endocrinol Metab       Date:  2020-10-12       Impact factor: 3.565

4.  The Differences Between Multifocal and Unifocal Papillary Thyroid Carcinoma in Unilateral Lobe: A Meta-Analysis.

Authors:  Ting Zhang; Liang He; Zhihong Wang; Wenwu Dong; Wei Sun; Ping Zhang; Hao Zhang
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

Review 5.  Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta-analysis.

Authors:  Likun Cui; Dongdong Feng; Chaofan Zhu; Qiuyu Li; Wenqing Li; Baoguo Liu
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-06-21

6.  Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.

Authors:  Ke-Cheng Jiang; Bei Lin; Yu Zhang; Ling-Qian Zhao; Ding-Cun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

7.  Predictive Factors for Bilateral Disease in Papillary Microcarcinoma: A Retrospective Cohort Study.

Authors:  Kirsten Lindner; K Alexander Iwen; Jochen Kußmann; Volker Fendrich
Journal:  Curr Oncol       Date:  2022-08-23       Impact factor: 3.109

8.  Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?

Authors:  Hyungju Kwon; Woosung Lim; Byung-In Moon
Journal:  Cancers (Basel)       Date:  2022-08-26       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.